Provention Bio is a clinical-stage biopharmaceutical company dedicated to sourcing, developing and commercializing novel therapeutics and cutting-edge solutions to intercept and prevent immune-mediated disease. The Company's “predict and prevent” model is focused on developing novel therapeutic approaches that intervene before the target disease begins, re-appears or progresses. Provention offers the potential to reduce the high morbidity, mortality, patient suffering and escalating costs of chronic autoimmune and inflammatory diseases, such as type 1 diabetes, Crohn’s disease, ulcerative colitis, and emerging viral infections.